Neurosurgery Quality

• 10+ neurosurgical centers including SGH, NUH, TTSH, CGH, SKH, KKH and four private hospitals with dedicated neurosurgical departments
• 57 registered neurosurgery specialists (2022), exceeding the 40+ threshold for Score 5
• Advanced technologies universally available: intraoperative MRI (SGH/NNI), Gamma Knife (NUH), CyberKnife (private), awake craniotomy with cortical mapping, DBS at multiple centers, fluorescence-guided surgery
• Complete subspecialty coverage: pediatric (KKH), functional (DBS/epilepsy), skull-base (NUH), vascular, spine, neuro-oncology, neurotrauma, peripheral nerve
• 0.8% operative mortality for brain tumor surgery at NNI, well below 3% international benchmark; 89.5% 1-year and 72.2% 5-year survival for pediatric brain tumors
• WFNS postgraduate fellowship training center; RACS advanced training approval (only in Singapore/SE Asia for FRACS Neurosurgery); AASNS fellowship recognition
• JCI accreditation at NHG institutions and private hospitals (Mount Elizabeth, Gleneagles); TTSH received Gold Award 2022 for infection control
• Six Singapore hospitals rank in Newsweek Asia-Pacific 2025 neurosurgery top 50; Changi General Hospital ranks #8
• Sophisticated medical tourism infrastructure: government IPSCs, Parkway Pantai Patient Assistance Centres serving 120+ countries, overseas offices in 15+ countries, dedicated international coordinators

Read the full Singapore report →

• Eight dedicated neurosurgical centers performing 8,500-10,000+ procedures annually: Ichilov (2,500/year), Sheba (1,200+), Rambam (1,200), Rabin (1,400+), Soroka (900+), Hadassah (700+), Schneider pediatric, Assuta
• Advanced technology comprehensive across multiple institutions: Intraoperative MRI (Ichilov, Soroka), Gamma Knife with 2,000+ cases, MRgFUS thalamotomy (177 published cases at Rambam), awake craniotomy (Ichilov), robotic DBS (Sheba, Rabin), LITT for epilepsy (Ichilov)
• Full subspecialty coverage: Pediatric (Schneider, Rabin, Hadassah), functional/DBS (Rabin, Sheba), skull base (Ichilov), epilepsy (Ichilov), spine oncology (Rambam), vascular (all major centers)
• Medical tourism: 30,000+ annual medical tourists, zero wait times for international patients, 24/7 multilingual coordinators, 60% cost savings vs. US
• International recognition: Sheba ranked #7 globally by Newsweek 2026; Israel ranked #8 Medical Tourism Index and #1 by IHRC for quality among 41 countries; multiple JCI-accredited centers
• Training infrastructure: Ichilov-NYU collaboration, Hadassah residency program, fellows from Europe/China/India/Africa; Israeli Neurosurgical Society affiliated with Congress of Neurological Surgeons

Read the full Israel report →

• 2,954 neurosurgeons as of May 2025 with 482 accredited annual training positions (highest globally)
• Five gamma knife centers, seven CyberKnife centers, and five intraoperative MRI facilities across India
• Comprehensive subspecialty coverage including pediatric neurosurgery, skull base surgery, vascular neurosurgery, epilepsy surgery, and neurointervention services
• 45-55 JCI-accredited hospitals with medical tourism industry generating $9+ billion annually
• Endovascular aneurysm treatment outcomes: 1.4% mortality with 5.4% complication rate (excellent)
• Surgeries scheduled within days; public hospitals average 1-2 day wait times
• Neurosurgeon-to-population ratio of 1 per 371,000 (far below developed country standards) with 2.67% practicing in rural areas
• Report explicitly notes lack of systematic outcome documentation: 'many centers do not have the wherewithal to meticulously document, retrieve, analyze, and follow up the large number of patients treated'

Read the full India report →

• 11 dedicated neurosurgical centers across four major cities with 6 JCI-accredited hospitals (Fundación Valle del Lili, FSFB, Hospital Pablo Tobón Uribe, Centro Médico Imbanaco, Hospital Internacional de Colombia, Fundación Cardioinfantil)
• 500+ practicing neurosurgeons at 0.96 per 100,000 population with 10 recognized residency programs and international training backgrounds
• Comprehensive subspecialty coverage including three active DBS centers (most in Latin America), CyberKnife radiosurgery (first in South America, 2012), Brainlab augmented reality neuronavigation, and specialized intraoperative imaging
• Institutional published outcomes: zero complications in 14 AR-assisted craniotomies (FSFB), 194-case ruptured aneurysm comparative study (Fundación Valle del Lili), 341 functional neurosurgery procedures documented (San Vicente Fundación)
• Strong international recognition: Fundación Valle del Lili ranked 1st nationally and 149th globally (Newsweek 2025), two hospitals hold World Stroke Organization Advanced Stroke Center status, FSFB partnership with Johns Hopkins Medicine International

Read the full Colombia report →

• 1,497 hospitals participated in Japan Neurosurgical Database (2019); 13 Japanese facilities ranked in Asia-Pacific top 50 for neurosurgery (Newsweek 2025), with University of Tokyo Hospital at #1 regionally
• 7,935 board-certified neurosurgeons as of September 2024, approximately 8 per 100,000 population; rigorous recertification every five years; 77% pass rate on specialty examination (2019)
• Brain tumor in-hospital mortality 3.0–3.1%; meningioma 0.59%; aneurysmal SAH 68.2% achieving good clinical outcomes (mRS ≤2) in surgical arm of JSAT trial
• ~50 Gamma Knife units; Nagoya University's intraoperative MRI 'Brain Theater' with Asia-first robotic neuronavigation; DBS approved and routinely performed; awake craniotomy standard at academic centers
• JCI accreditation at University of Tokyo, NTT Medical Center Tokyo, Nagoya University Hospital, St. Luke's International; WFNS-recognized training centers at Nippon Medical School, Keio University (international fellowship program), and Fujita Health University

Read the full Japan report →

• 15+ dedicated neurosurgical departments distributed across Malaysia, including IKTAR (national center with 15 consultant neurosurgeons), 4 public university hospitals, and extensive private network
• Advanced technology at leading centers: UM CIGMIT (unique intraoperative MRI-CT-LINAC suite in region), Gamma Knife at Sunway, neuronavigation and awake craniotomy at UMMC, first-in-Southeast Asia Percept RC BrainSense adaptive DBS implanted October 2024
• ~80 active neurosurgeons (NAM membership) with international training; many trained in UK/USA/Australia; 88% at Island Hospital hold international credentials
• Comprehensive subspecialties: UMMC offers all 9 subspecialties (skull base, pediatric, functional/DBS, epilepsy, neuro-oncology, spine, neurovascular, pain/interventional, radiosurgery)
• Published outcome data: DBS hemorrhage rate 1.9% (international standard); emergency craniotomy at trauma center 10.39% in-hospital mortality (context: public hospital emergency cases, not elective private care)
• Multiple JCI-accredited centers: Sunway, Gleneagles KL/Medini, Pantai KL/Penang, SJMC, KPJ Ampang Puteri; Newsweek 2024 ranked Sunway top 75 Asia-Pacific for neurosurgery
• Mature medical tourism infrastructure: MHTC (1.6M international patients 2024, RM 2.72B revenue), dedicated international patient units, 1-4 week wait times for elective procedures
• Two accredited Masters-level training programs producing 110+ certified neurosurgeons; USM program uses international examiners from six continents

Read the full Malaysia report →

• Germany has 2,446 board-certified neurosurgeons, the highest density in Europe at 2.94 per 100,000 inhabitants (vs. European mean of 1.46)
• Charité – Universitätsmedizin Berlin ranked #2 globally in neurosurgery by Newsweek 2025, with additional top-ranked centers at Heidelberg (#20), Hannover (#29), and Bonn (#41)
• Intraoperative MRI available at Tübingen (Europe's first high-field ceiling-mounted system), Heidelberg, Munich, and Charité; 15+ Gamma Knife centers and European CyberKnife center at Munich LMU
• Overall in-hospital mortality 3.8% across 222,158 cases (2023), with primary brain tumor resection at 3.9%, benign meningeal tumor at 1.3%, and spinal disc surgery at 0.5%
• Elective procedure wait times 1–3 weeks; approximately 250,000 international patients annually across all specialties, with dedicated medical tourism brokers (Booking Health, Best Clinic Abroad, AiroMedical)

Read the full Germany report →

• 32+ dedicated neurosurgical units across Great Britain with 8 in London alone, exceeding the 10+ required for a 5
• 500–600 consultant neurosurgeons practicing nationally (far exceeds 40+ requirement)
• Three UK institutions in Newsweek World's Best Specialized Hospitals 2025 rankings for neurosurgery: NHNN #7 globally (highest-ranked UK), King's College Hospital #24, Addenbrooke's #35
• Elective 30-day cranial surgery mortality 0.4–0.5% nationally (far below 3% threshold) with NNAP publishing annual risk-adjusted benchmarks for all 24 NHS units
• World-first Gamma Knife Esprit system installed at Royal Hallamshire Sheffield in January 2023; intraoperative MRI at NHNN and Wellington Hospital; CyberKnife, proton therapy, awake craniotomy at majority of centers, DBS programs at multiple NHS centers
• Comprehensive subspecialty services including pediatric, functional, vascular, skull base, epilepsy, neuro-oncology (King's largest in UK/Europe), and fetal neurosurgery (King's—one of 10 centers worldwide)
• Established medical tourism infrastructure: over 100,000 international patients annually to London; dedicated international wards and private consulting rooms at NHNN; Wellington Hospital with dedicated international concierge; private sector offers <4-week wait times via same consultant neurosurgeons
• NHS elective waiting times exceed 18 weeks for 55% of patients (median 173 days in some regions), falling short of the <4-week standard, though not applicable to private-sector patients

Read the full United Kingdom report →

• 12+ neurosurgical centers including CCAD (600+ annual neurosurgeries), Burjeel Medical City (200+ annual brain tumors), Sheikh Shakhbout Medical City, Neuro Spinal Hospital Dubai, Rashid Hospital trauma center (top 10 MENA/Europe), Al Jalila Children's Hospital pediatric center
• Advanced technology leadership: intraoperative 3-T MRI (first UAE), CyberKnife M6 (first Middle East), Gamma Knife, Elekta Versa HD, ARTIS Icono endovascular, LITT (first Gulf — 2026), O-arm with Stealth navigation, 3D-printed implants
• Workforce: 194 neurosurgery professionals licensed in Dubai alone (110 at consultant level), plus Abu Dhabi cohort; internationally trained from US/UK/European programs
• Comprehensive subspecialties: functional neurosurgery (75+ DBS procedures since 2020, SEEG, VNS), skull base (NASBS Multidisciplinary Team of Distinction — only outside US), Level 4 epilepsy center with 24/7 monitoring, pediatric neurosurgery (Al Jalila + Burjeel Neuro-PICU)
• Medical tourism infrastructure: first consultation within 48 hours, elective surgery within days, 208+ JCI-accredited organizations (highest Middle East concentration), 35 hospitals in Newsweek 2026 regional rankings, dedicated international coordinators
• Process metrics: 35-minute median tPA time (40% faster than 60-minute standard), Rashid Hospital trauma center top 10 MENA/Europe, multiple first-in-region technology adoptions
• Transparency gap: no centralized national neurosurgical outcomes database published; individual institutional quality reporting but no population-level mortality registry comparable to UK NSAN

Read the full United Arab Emirates report →

• OKITI/Semmelweis ranked as Europe's 3rd largest neurosurgical centre with 3,000 major surgeries annually and highest interventional thrombectomy volumes in Europe
• Six dedicated neurosurgical departments (Budapest, Szeged, Debrecen, Pécs, Miskolc/Army Medical Centre, Szombathely) plus specialized spine and radiosurgery centers providing comprehensive geographic coverage
• Advanced technology widely deployed: ROSA robot-assisted system (first in CEE, 2018), Gamma Knife radiosurgery with 5,000+ procedures at Debrecen, neuronavigation, intraoperative real-time monitoring, AI-assisted stroke support (e-Stroke)
• Comprehensive subspecialty services including only national pediatric neurosurgery program, functional neurosurgery with DBS established 2010, epilepsy surgery, skull base surgery, and spinal disorder treatment
• Limited published outcome data: no national neurosurgical mortality database comparable to UK/German registries; absence of procedure-specific mortality/complication rates in public domain

Read the full Hungary report →

• 1,200+ neurosurgeons in Turkey with 83 training programs providing comprehensive workforce capacity
• Advanced technologies widely available including intraoperative MRI at Medipol and Hisar hospitals, Gamma Knife at multiple centers treating 9,300+ patients, and CyberKnife at major hospitals
• Comprehensive subspecialty coverage including neurooncology, neurovascular surgery, skull base surgery, epilepsy surgery, and pediatric neurosurgery with Dr. Ozek's 10,000+ pediatric procedures
• 50+ JCI-certified hospitals with dedicated international patient departments offering multilingual support and coordination services across Istanbul, Ankara, and Antalya
• Published outcome data showing 91% success rates for brain tumor surgery and 1.6% mortality in pediatric epilepsy surgery, though national outcome databases lack transparency
• Fast patient access with scheduling within days of arrival and multilingual staff supporting medical tourism infrastructure
• Variable training quality acknowledged with disparities between accredited university hospitals and smaller training facilities, plus limited neurointensive care specialist availability (only 29 trained specialists)

Read the full Turkey report →

• 2,069 board-certified neurosurgeons with WFNS leadership representation (President-Elect Luis Borba)
• Three hospitals ranked in Newsweek's global top 50 for neurosurgery with JCI accreditation
• Advanced technologies widely available: Gamma Knife, intraoperative MRI, neuronavigation, DBS, 5-ALA fluorescence
• Comprehensive subspecialty coverage including vascular, functional, pediatric, skull base, and neuro-oncology
• Published outcome data: 12.7% adverse event rate and 4.2% revision rate in prospective intracranial tumor surgery; DBS outcomes consistent with international benchmarks
• Well-developed medical tourism infrastructure with bilingual coordination and <4 week wait times at leading private centers

Read the full Brazil report →

• 58 board-certified neurosurgeons with international training, exceeding the 40+ threshold for Score 5
• Advanced technologies widely available at major centers: Gamma Knife (since 1996), intraoperative MRI Brain Suite (KHCC), robotic-guided surgery (KHCC, 2022), neuronavigation, and Zeiss Pentero microscopes
• Comprehensive subspecialty coverage: cranial, spinal, vascular, functional, skull base, pediatric, and peripheral nerve surgery
• Published outcome data from KHCC: meningioma 5-year survival 84%, pediatric circumscribed astrocytoma 92%, medulloblastoma 67%
• Multiple JCI-accredited hospitals (10 JCI centers nationwide); WFNS-recognized training center since 2007
• Established medical tourism ecosystem: 224,000+ international patients in 2024, no reported waiting lists, 25-40% cost savings, multilingual coordination
• Limitation: Only 8 documented dedicated neurosurgery centers (below 10+ for Score 5); all concentrated in Amman
• Limitation: No centralized national neurosurgical outcomes/mortality registry, restricting benchmarking against international standards

Read the full Jordan report →

• 14 JCI-accredited clinics offering neurosurgical procedures, plus INNN and other major centers (INNN is largest training center in Latin America)
• Advanced technologies widely available: Gamma Knife (20+ years experience, 1000+ patients treated), CyberKnife, 3D surgical navigation systems, robotic-assisted surgery, Tesla MR systems
• 100+ board-certified neurosurgeons estimated based on FLANC data (1.4 per 100,000 inhabitants for Latin America applied to Mexico's 128M population); INNN alone graduated >200 neurosurgery specialists 1967-2010
• Several subspecialties documented: functional neurosurgery (DBS for Parkinson's), spine surgery, vascular surgery (aneurysm/malformation repair), brain tumors; pediatric and skull base surgery not explicitly confirmed
• Published outcome data: one center reports >98% success rate treating brain/pituitary tumors; infection rates 3.5% pre-pandemic (published data), returned to baseline
• Medical tourism infrastructure: >20,000 international patients yearly with 92% satisfaction score; cost 50-70% lower than US/Europe
• Wait times appear <4 weeks: clinic reports appointments available without major waiting period
• Recognized training: Mexican Board of Neurological Surgery recognized by American Association of Neurological Surgeons and Royal College of Physicians and Surgeons of Canada

Read the full Mexico report →

• Approximately 500 board-certified neurosurgeons (vs. 40+ required for Score 5)
• 40 centers with comprehensive subspecialty coverage across 8+ major cities; Gamma Knife Center Warsaw, intraoperative MRI-guided suite at Bródno, CyberKnife center operational
• Published outcome data: 6.7–7.6% in-hospital mortality for aneurysm surgery 2009–2012 (exceeds <3% Score 5 benchmark); 2.83% complication rate for outpatient spine surgery 2018–2021
• Comprehensive subspecialties including AADC gene therapy (second worldwide), Tabakow spinal cord repair research, pediatric neurosurgery, functional neurosurgery, skull base surgery
• 2–4 week consultation-to-surgery timelines via private pathways; established international patient coordinators, cost 40–70% below Western Europe
• Polish Society of Neurosurgeons secured EANS 2028 Congress; full EANS/WFNS membership; documented protocol standardization gaps in SAH management (2020 survey)

Read the full Poland report →

• At least 5-9 major neurosurgical centers identified: Bumrungrad International Hospital, Siriraj Hospital, Ramathibodi Hospital, Vejthani Hospital, Bangkok International Hospital, and Samitivej Hospital with comprehensive subspecialty coverage
• Advanced technologies widely available at major centers: intraoperative MRI and neuronavigation at Bangkok Hospital, Gamma Knife at Bumrungrad Neuroscience Center and additional facilities, CyberKnife at several centers, endoscopic procedures, and Hybrid Operating Rooms with integrated imaging
• 13 Thai hospitals accredited by Joint Commission International (JCI), with Bumrungrad being the first hospital in Asia to achieve JCI accreditation in 2002
• Exceptional medical tourism infrastructure: 118,964 medical tourists at Bumrungrad through August 2023, multilingual support (9 languages at Vejthani), travel coordinators, telemedicine consultations, and short wait times (1-3 days to same-day appointments)
• Critical limitation: neurointensive care units and neurointensivists 'rarely available in Thailand' with only 6% of Siriraj Hospital's ~2,000 beds allocated as ICU beds, creating insufficient post-operative critical care capacity for complex cases

Read the full Thailand report →